Kura Oncology, Inc.
Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives.
Funding history
About Kura Oncology, Inc.
How much funding has Kura Oncology, Inc. raised?
Kura Oncology, Inc. has raised $150.0M in total funding. The most recent round was Series B.
Where is Kura Oncology, Inc. headquartered?
Kura Oncology, Inc. is headquartered in San Diego, CA.
What does Kura Oncology, Inc. do?
Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives.
What problem does Kura Oncology, Inc. solve?
Cancers such as head and neck cancer, lung cancer, and acute leukemias are areas of highest unmet need where patients need better, longer-lasting outcomes.
What's Kura Oncology, Inc.'s solution?
Discovers and develops precision cancer therapeutics designed to selectively target cancer cells, including in combination with existing standards of care.
What makes Kura Oncology, Inc. different?
Pipeline is built specifically around menin inhibition and farnesyl transferase inhibitor technologies aimed at overcoming treatment resistance.
What makes Kura Oncology, Inc. notable?
Kura Oncology CEO and co-founder Troy Wilson made a notable open-market purchase of roughly $1.24 million of company stock, an insider buy that drew attention from investors.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.